Loading...
XSHG
603880
Market cap274mUSD
Dec 05, Last price  
6.72CNY
1D
3.38%
1Q
6.84%
IPO
3.35%
Name

Jiangsu Nanfang Medical Co Ltd

Chart & Performance

D1W1MN
XSHG:603880 chart
P/E
P/S
3.22
EPS
Div Yield, %
Shrs. gr., 5y
0.23%
Rev. gr., 5y
4.15%
Revenues
603m
+0.42%
424,621,054510,798,291469,803,419433,022,478444,235,500488,708,743479,823,815491,688,0111,072,399,917527,440,662545,369,151600,095,343602,615,333
Net income
-191m
L+29.34%
35,767,10348,044,64553,380,20051,242,68651,980,39047,601,36739,250,11928,051,59598,067,61300-147,417,266-190,668,979
CFO
63m
+308.27%
76,074,46920,142,29873,518,72690,664,00699,350,00149,236,92652,749,49232,994,069154,122,592031,276,44815,509,53163,320,497
Dividend
May 21, 20210.115385 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal products, medical proof fabrics, adhesive tapes, bandages, sports protection products, first-aid kits, and care products in China and internationally. It offers medical adhesive tapes, medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, and masks, as well as customized products. The company was founded in 1990 and is based in Changzhou, China.
IPO date
Aug 07, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT